Nuacht

JPMorgan Calls the Selloff Excessive, Trims Regeneron Pharmaceuticals, Inc. (REGN) Price Target
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has ...
Investing Snacks9 lá
Regeneron Gets a Trim—But Still Packs a Punch
Regeneron Pharmaceuticals just got a haircut from Wall Street, with JPMorgan Chase & Co. lowering its price target from $950 ...
Investing Snacks1 lá
Regeneron Gets a Shot of Investor Confidence
Factory Mutual Insurance Co. dramatically upped its stake in Regeneron Pharmaceuticals by 210.3%, acquiring an additional ...
Investing17 lá
bernstein socgen lowers regeneron pharma stock price target
On Monday, Bernstein SocGen Group lowered the price target for Regeneron Pharma stock (NASDAQ: NASDAQ:REGN) to $750 from $896, while maintaining an Outperform rating. This adjustment follows ...
Investopedia15 lá
Pinterest Stock Gains on JPMorgan Rating Upgrade, Price Target Raise
Jaque Silva / NurPhoto / Getty Images Pinterest shares rose in premarket trading Tuesday after JPMorgan analysts upgraded their rating and lifted their price target on the social media stock.
Investopedia29 lá
Uber Stock Sets Fresh All-Time High as JPMorgan Increases Price Target
Klaudia Radecka / NurPhoto via Getty Images Shares of Uber Technologies hit a fresh record high Tuesday morning as JPMorgan analysts increased their price target on the ride-sharing firm's stock.